Latest & greatest articles for knee replacement

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on knee replacement or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on knee replacement and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for knee replacement

81. Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults National Institute for Health and Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation National Institute for Health and Clinical Excellence. Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults. London: National Institute for Health and Clinical Excellence (NICE). Technology Appraisal Guidance 170. 2009 Authors' conclusions Rivaroxaban, within its marketing authorisation, is recommended as an option for the prevention of venous thromboembolism in adults having elective total hip

Health Technology Assessment (HTA) Database.2009

82. Prostheses for primary total knee replacement in Italy

Prostheses for primary total knee replacement in Italy Prostheses for primary total knee replacement in Italy Prostheses for primary total knee replacement in Italy Cerbo M, Fella D, Jefferson T, Migliore A, Paone S, Perrini MR, Velardi L Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Cerbo M, Fella D, Jefferson T, Migliore A, Paone S (...) , Perrini MR, Velardi L. Prostheses for primary total knee replacement in Italy. Rome: Agenzia nazionale per i servizi sanitari regionali. 2009 Authors' objectives We aimed to identify the TKR prostheses currently used in Italy, to retrieve evidence of performance for all the models identified from clinical studies and arthroplasty registers, and to construct a cost-effectiveness model to support the choice for healthcare payers. Authors' conclusions Despite the limitations and constraints of our study

Health Technology Assessment (HTA) Database.2009

83. A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the Irish healthcare setting

A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the Irish healthcare setting A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the Irish healthcare setting A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium (...) as thromboprophylaxis after total hip and total knee replacement in the Irish healthcare setting McCullagh L, Tilson L, Walsh C, Barry M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of rivaroxaban

NHS Economic Evaluation Database.2009

84. Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery

Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery Wolowacz S E, Roskell N S, Maciver F, Beard S M, Robinson P A, Plumb J M, Dolan G, Brenkel I J (...) Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study examined the cost-effectiveness of oral dabigatran etexilate (DE) versus subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement

NHS Economic Evaluation Database.2009

85. Survival and clinical function of cemented and uncemented prostheses in total knee replacement: a meta-analysis

Survival and clinical function of cemented and uncemented prostheses in total knee replacement: a meta-analysis Survival and clinical function of cemented and uncemented prostheses in total knee replacement: a meta-analysis Survival and clinical function of cemented and uncemented prostheses in total knee replacement: a meta-analysis Gandhi R, Tsvetkov D, Davey JR, Mahomed NN CRD summary This review compared survival and clinical outcomes of cemented and uncemented techniques in primary total (...) knee replacement and concluded that there was improved survival for cemented implants. Given the presence of publication bias, uncertain study quality and conclusions based on pooling of two study types, the authors' conclusions should be interpreted with caution. Authors' objectives To compare survival and clinical outcomes of cemented and uncemented techniques in primary total knee replacement. Searching PubMed, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Central Register

DARE.2009

86. Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

Apixaban or enoxaparin for thromboprophylaxis after knee replacement. 19657123 2009 08 06 2009 08 11 2014 11 20 1533-4406 361 6 2009 Aug 06 The New England journal of medicine N. Engl. J. Med. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. 594-604 10.1056/NEJMoa0810773 The optimal strategy for thromboprophylaxis after major joint replacement has not been established. Low-molecular-weight heparins such as enoxaparin predominantly target factor Xa but to some extent also (...) inhibit thrombin. Apixaban, a specific factor Xa inhibitor, may provide effective thromboprophylaxis with a low risk of bleeding and improved ease of use. In a double-blind, double-dummy study, we randomly assigned patients undergoing total knee replacement to receive 2.5 mg of apixaban orally twice daily or 30 mg of enoxaparin subcutaneously every 12 hours. Both medications were started 12 to 24 hours after surgery and continued for 10 to 14 days. Bilateral venography was then performed. The primary

NEJM2009

87. Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults (TA170)

Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults (TA170) Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults | Guidance and guidelines | NICE Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults Technology appraisal guidance [TA170] Published date: 22 April 2009 Share Guidance wherever possible. Explore Guidance app

National Institute for Health and Clinical Excellence - Technology Appraisals2009

88. Rivaroxaban and dabigatran for thromboprophylaxis in patients undergoing total hip or knee replacement

Rivaroxaban and dabigatran for thromboprophylaxis in patients undergoing total hip or knee replacement Home - Monash Health Find a Location Latest news We are delighted to begin construction on the Victorian Heart Hospital, Australia’s first dedicated state-of-the art cardiac facility. Your health Protect your health and safety while you travel this holiday season by planning ahead and preparing for the unexpected. Our children’s hospital Monash Children’s Hospital is one of Australia’s leading

Monash Health Evidence Reviews2009

90. Pre-operative injections of epoetin-{alpha} versus post-operative retransfusion of autologous shed blood in total hip and knee replacement

Pre-operative injections of epoetin-{alpha} versus post-operative retransfusion of autologous shed blood in total hip and knee replacement 18669967 2008 08 01 2008 10 28 2015 11 19 0301-620X 90 8 2008 Aug The Journal of bone and joint surgery. British volume J Bone Joint Surg Br Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial. 1079-83 10.1302/0301-620X.90B8.20595 (...) This prospective randomised clinical trial evaluated the effect of alternatives for allogeneic blood transfusions after total hip replacement and total knee replacement in patients with pre-operative haemoglobin levels between 10.0 g/dl and 13.0 g/dl. A total of 100 patients were randomly allocated to the Eprex (pre-operative injections of epoetin) or Bellovac groups (post-operative retransfusion of shed blood). Allogeneic blood transfusions were administered according to hospital policy. In the Eprex group, 4

EvidenceUpdates2008

91. Computer-assisted and conventional total knee replacement

Computer-assisted and conventional total knee replacement 18669959 2008 08 01 2008 10 28 2016 11 24 2044-5377 90 8 2008 Aug The Journal of bone and joint surgery. British volume J Bone Joint Surg Br Computer-assisted and conventional total knee replacement: a comparative, prospective, randomised study with radiological and CT evaluation. 1039-44 10.1302/0301-620X.90B8.20553 After obtaining informed consent, 80 patients were randomised to undergo a navigated or conventional total knee (...) replacement. All received a cemented, unconstrained, cruciate-retaining implant with a rotating platform. Full-length standing and lateral radiographs and CT scans of the hip, knee and ankle joint were carried out five to seven days after operation. No notable differences were found between computer-assisted navigation and conventional implantation techniques as regards the rotational alignment of the femoral or tibial components. Although the deviation from the transepicondylar axis was relatively low

EvidenceUpdates2008

92. After partial knee replacement, patients can kneel, but they need to be taught to do so: a single-blind randomized controlled trial

After partial knee replacement, patients can kneel, but they need to be taught to do so: a single-blind randomized controlled trial 18635671 2008 09 01 2008 09 23 2015 11 19 1538-6724 88 9 2008 Sep Physical therapy Phys Ther After partial knee replacement, patients can kneel, but they need to be taught to do so: a single-blind randomized controlled trial. 1012-21 10.2522/ptj.20070374 Kneeling is an important functional activity frequently not performed after knee replacement, thus affecting (...) a patient's ability to carry out basic daily tasks. Despite no clinical reason preventing kneeling, many patients fail to resume this activity. The purpose of this study was to determine whether a single physical therapy intervention would improve patient-reported kneeling ability following partial knee replacement (PKR). Sixty adults with medial compartment osteoarthritis, suitable for a PKR, participated. This was a single-blind, prospective randomized controlled trial. Six weeks after PKR, participants

EvidenceUpdates2008

93. Patient-reported outcomes after fixed- versus mobile-bearing total knee replacement: a multi-centre randomised controlled trial using the Kinemax total knee replacement

Patient-reported outcomes after fixed- versus mobile-bearing total knee replacement: a multi-centre randomised controlled trial using the Kinemax total knee replacement 18757956 2008 09 01 2008 10 31 2016 11 24 0301-620X 90 9 2008 Sep The Journal of bone and joint surgery. British volume J Bone Joint Surg Br Patient-reported outcomes after fixed- versus mobile-bearing total knee replacement: a multi-centre randomised controlled trial using the Kinemax total knee replacement. 1172-9 10.1302/0301 (...) -620X.90B9.21031 We compared patient-reported outcomes of the Kinemax fixed- and mobile-bearing total knee replacement in a multi-centre randomised controlled trial. Patients were randomised to the fixed- or the mobile-bearing prosthesis via a sealed envelope method after the bone cuts had been made in the operating theatre. Randomisation was stratified by centre and diagnosis. Patients were assessed pre-operatively and at eight to 12 weeks, one year and two years post-operatively. Validated

EvidenceUpdates2008

94. Inpatient compared with home-based rehabilitation following primary unilateral total hip or knee replacement: a randomized controlled trial

Inpatient compared with home-based rehabilitation following primary unilateral total hip or knee replacement: a randomized controlled trial 18676897 2008 08 04 2008 09 04 2016 05 12 1535-1386 90 8 2008 Aug The Journal of bone and joint surgery. American volume J Bone Joint Surg Am Inpatient compared with home-based rehabilitation following primary unilateral total hip or knee replacement: a randomized controlled trial. 1673-80 10.2106/JBJS.G.01108 Home-based rehabilitation is increasingly (...) utilized to reduce health-care costs; however, with a shorter hospital stay, the possibility arises for an increase in adverse clinical outcomes. We evaluated the effectiveness and cost of care of home-based compared with inpatient rehabilitation following primary total hip or knee joint replacement. We randomized 234 patients, using block randomization techniques, to either home-based or inpatient rehabilitation following total joint replacement. All patients followed standardized care pathways and

EvidenceUpdates2008

95. Total knee replacement performed with either a mini-midvastus or a standard approach

Total knee replacement performed with either a mini-midvastus or a standard approach 18450623 2008 05 02 2008 09 04 2016 11 24 0301-620X 90 5 2008 May The Journal of bone and joint surgery. British volume J Bone Joint Surg Br Total knee replacement performed with either a mini-midvastus or a standard approach: a prospective randomised clinical and radiological trial. 584-91 10.1302/0301-620X.90B5.20122 We report the clinical and radiological results of a two- to three-year prospective (...) randomised study which was designed to compare a minimally-invasive technique with a standard technique in total knee replacement and was undertaken between January 2004 and May 2007. The mini-midvastus approach was used on 50 patients (group A) and a standard approach on 50 patients (group B). The mean follow-up in both groups was 23 months (24 to 35). The functional outcome was better in group A up to nine months after operation, as shown by statistically significant differences in the mean function

EvidenceUpdates2008

96. Dabigatran Etexilate - Primary prevention of venous thromboembolic events in adult patients who have undergone total hip replacement surgery or total knee replacement surgery

Dabigatran Etexilate - Primary prevention of venous thromboembolic events in adult patients who have undergone total hip replacement surgery or total knee replacement surgery

Scottish Medicines Consortium2008

97. Accelerated perioperative care and rehabilitation intervention for hip and knee replacement is effective: a randomized clinical trial involving 87 patients with 3 months of follow-up

Accelerated perioperative care and rehabilitation intervention for hip and knee replacement is effective: a randomized clinical trial involving 87 patients with 3 months of follow-up 18478482 2008 05 14 2008 05 27 2009 12 11 1745-3682 79 2 2008 Apr Acta orthopaedica Acta Orthop Accelerated perioperative care and rehabilitation intervention for hip and knee replacement is effective: a randomized clinical trial involving 87 patients with 3 months of follow-up. 149-59 10.1080/17453670710014923 (...) Approximately 12,000 hip and knee replacements were performed in Denmark in 2005. Accelerated perioperative interventions are currently implemented, but there is conflicting evidence regarding the effect. We therefore performed an efficacy study of an accelerated perioperative care and rehabilitation intervention in patients receiving primary total hip replacement, and both total and unicompartmental knee replacement. A randomized clinical trial was undertaken in which 87 patients were randomized to either

EvidenceUpdates2008

98. Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chronic arthropathy.

Multidisciplinary rehabilitation programmes following joint replacement at the hip and knee in chronic arthropathy. BACKGROUND: Joint replacements are common procedures and treatment of choice for those with intractable joint pain and disability arising from arthropathy of the hip or knee. Multidisciplinary rehabilitation is considered integral to the outcome of joint replacement. OBJECTIVES: To assess the evidence for effectiveness of multidisciplinary rehabilitation on activity (...) and participation in adults following hip or knee joint replacement for chronic arthropathy. SEARCH STRATEGY: We searched the Cochrane Musculoskeletal Group Trials Register, the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE and CINAHL up to September 2006. SELECTION CRITERIA: Randomised controlled trials (RCTs) that compared organised multidisciplinary rehabilitation with routine services following hip or knee replacement, and included outcome measures of activity and participation

Cochrane2008

99. A prospective randomised double-blind study of functional outcome and range of flexion following total knee replacement with the NexGen standard and high flexion components

A prospective randomised double-blind study of functional outcome and range of flexion following total knee replacement with the NexGen standard and high flexion components 18160497 2007 12 27 2008 05 08 2011 12 09 0301-620X 90 1 2008 Jan The Journal of bone and joint surgery. British volume J Bone Joint Surg Br A prospective randomised double-blind study of functional outcome and range of flexion following total knee replacement with the NexGen standard and high flexion components. 37-42 (...) Modifications in the design of knee replacements have been proposed in order to maximise flexion. We performed a prospective double-blind randomised controlled trial to compare the functional outcome, including maximum knee flexion, in patients receiving either a standard or a high flexion version of the NexGen legacy posterior stabilised total knee replacement. A total of 56 patients, half of whom received each design, were assessed pre-operatively and at one year after operation using knee scores

EvidenceUpdates2008

100. Total knee replacement with and without patellar resurfacing: A Prospective, randomised trial using the profix total knee system

Total knee replacement with and without patellar resurfacing: A Prospective, randomised trial using the profix total knee system 18160498 2007 12 27 2008 05 08 2011 12 09 2044-5377 90 1 2008 Jan The Journal of bone and joint surgery. British volume J Bone Joint Surg Br Total knee replacement with and without patellar resurfacing: a prospective, randomised trial using the profix total knee system. 43-9 We have examined the differences in clinical outcome of total knee replacement (TKR (...) @exchange.curtin.edu.au Wood D J DJ Li M-G MG eng Journal Article Multicenter Study Randomized Controlled Trial England J Bone Joint Surg Br 0375355 0301-620X AIM IM Aged Aged, 80 and over Arthralgia Arthroplasty, Replacement, Knee methods Double-Blind Method Female Humans Knee Joint surgery Knee Prosthesis Male Middle Aged Osteoarthritis, Knee surgery Pain Measurement Patella surgery Patient Satisfaction Prospective Studies Prosthesis Design Treatment Outcome 2007 12 28 9 0 2008 5 9 9 0 2007 12 28 9 0 ppublish

EvidenceUpdates2008